Pritesh Shah
No más puestos en curso
Fortuna: 2 M $ al 29/02/2024
Perfil
Pritesh Shah is former Chief Growth Officer for NovoCure Ltd.
and former Marketing Director-Oncology Pipeline at OSI Pharmaceuticals, Inc.
Dr. Shah received a doctorate from the University of Maryland and a graduate degree from Seton Hall University.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
NOVOCURE LTD.
0.12% | 07/11/2023 | 124 511 ( 0.12% ) | 2 M $ | 29/02/2024 |
Antiguos cargos conocidos de Pritesh Shah.
Empresas | Cargo | Fin |
---|---|---|
NOVOCURE LIMITED | Corporate Officer/Principal | 01/01/2024 |
OSI PHARMACEUTICALS, INC. | Sales & Marketing | - |
Formación de Pritesh Shah.
Seton Hall University | Graduate Degree |
University of Maryland | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
NOVOCURE LIMITED | Health Technology |
Empresas privadas | 1 |
---|---|
OSI Pharmaceuticals, Inc.
OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OSI Pharmaceuticals, Inc. manufactured and develope dpharmaceutical drugs. The company was founded in 1983 and was headquartered in Farmingdale, NY. | Health Technology |